{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:42:35Z","timestamp":1790037755702,"version":"4.0.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"German Consortium for Translational Cancer Research (DKTK)"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0195802","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T19:31:26Z","timestamp":1524079886000},"page":"e0195802","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model"],"prefix":"10.1371","volume":"13","author":[{"given":"Svetlana N.","family":"Rylova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Stoykow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Del Pozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keelara","family":"Abiraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Tamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Kiefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melpomeni","family":"Fani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut R.","family":"Maecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,4,18]]},"reference":[{"key":"ref1","first-page":"437","article-title":"Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy","volume":"58","author":"M de Jong","year":"1998","journal-title":"Cancer Res"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2967\/jnumed.108.061457","article-title":"Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues","volume":"50","author":"B Waser","year":"2009","journal-title":"J Nucl Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nchem.1832","article-title":"A stitch in time","volume":"6","author":"X Deupi","year":"2014","journal-title":"Nat Chemistry"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2967\/jnumed.116.177733","article-title":"Highly increased 125I-JR11 antagonist binding in vitro reveals novel indications for sst2 targeting in human cancers","volume":"58","author":"JC Reubi","year":"2017","journal-title":"J Nucl Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"16436","DOI":"10.1073\/pnas.0607761103","article-title":"Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors","volume":"103","author":"M Ginj","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2967\/jnumed.111.087999","article-title":"PET of somatostatin receptor-positive tumors using <sup>64<\/sup>Cu- and <sup>68<\/sup>Ga-somatostatin antagonists: the chelate makes the difference","volume":"52","author":"M Fani","year":"2011","journal-title":"J Nucl Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.2967\/jnumed.111.088922","article-title":"First clinical evidence that imaging with somatostatin receptor antagonists is feasible","volume":"52","author":"D Wild","year":"2011","journal-title":"J Nucl Med"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2967\/jnumed.117.191684","article-title":"Biodistribution, pharmacokinetics, and dosimetry of (177)Lu-, (90)Y-, and (111)In-labeled somatostatin receptor antagonist OPS201 in comparison to the agonist (177)Lu-DOTATATE: the mass effect","volume":"58","author":"GP Nicolas","year":"2017","journal-title":"J Nucl Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10967-017-5323-x","article-title":"Somatostatin analogues labelled with cooper radioisotopes: current status","volume":"313","author":"A Marciniak","year":"2017","journal-title":"J Radioanal Nucl Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/ar800255q","article-title":"Molecular imaging of cancer with Copper-64 radiopharmaceuticals and positron emission tomography (PET)","volume":"42","author":"M Shokeen","year":"2009","journal-title":"Accounts Chem Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0969-8051(96)00157-6","article-title":"Efficient production of high specific activity <sup>64<\/sup>Cu using a biomedical cyclotron","volume":"24","author":"DW McCarthy","year":"1997","journal-title":"Nucl Med Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/138161207779313768","article-title":"Copper chelation chemistry and its role in copper radiopharmaceuticals","volume":"13","author":"TJ Wadas","year":"2007","journal-title":"Current Pharm Design"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1021\/jm070204r","article-title":"Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents","volume":"50","author":"JE Sprague","year":"2007","journal-title":"J Med Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1039\/C5RA21131J","article-title":"Synthesis, 64Cu-labeling and PET imaging of 1,4,7-triazacyclononane derived chelators with pendant azaheterocyclic arms","volume":"6","author":"C Gotzmann","year":"2016","journal-title":"RSC Advances"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nucmedbio.2014.09.009","article-title":"Comparison of DOTA and NODAGA as chelators for 64Cu-labeled immunoconjugates","volume":"43","author":"SC Ghosh","year":"2015","journal-title":"Nucl Med Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1021\/bc300037w","article-title":"Comparison of <sup>64<\/sup>Cu-complexing bifunctional chelators for radioimmunoconjugation: labelling efficiency, specific activity and in vitro\/ in vivo stability","volume":"23","author":"MS Cooper","year":"2012","journal-title":"Bioconj Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1874471011104020109","article-title":"Sun X Recent advances in copper radiopharmaceuticals","volume":"4","author":"G Hao","year":"2011","journal-title":"Current Radiopharm"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/157340611796799177","article-title":"The development of copper radiopharmaceuticals for imaging and therapy","volume":"7","author":"M Shokeen","year":"2011","journal-title":"Med Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2967\/jnumed.112.102764","article-title":"Unexpected sensitivity of sst2 antagonists to N-terminal radiometal modifications","volume":"53","author":"M Fani","year":"2012","journal-title":"J Nucl Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2967\/jnumed.116.180430","article-title":"Head-to-head comparison of (64)Cu-DOTATATE and (68)Ga-DOTATOC PET\/CT: a prospective study of 59 patients with neuroendocrine tumors","volume":"58","author":"CB Johnbeck","year":"2017","journal-title":"J Nucl Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2967\/jnumed.115.156539","article-title":"64Cu-DOTATATE PET for neuroendocrine tumors: a prospective head-to-head comparison with 111In-DTPA-octreotide in 112 patients","volume":"56","author":"A Pfeifer","year":"2015","journal-title":"J Nucl Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1021\/jm701618q","article-title":"Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting","volume":"51","author":"R Cescato","year":"2008","journal-title":"J Med Chem"},{"key":"ref23","first-page":"1561","article-title":"Evaluation of [<sup>99m<\/sup>Tc\/EDDA\/HYNIC0]octreotide derivatives compared with [<sup>111<\/sup>In-DOTA<sup>0<\/sup>,Tyr<sup>3<\/sup>, Thr<sup>8<\/sup>]octreotide and [<sup>111<\/sup>In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?","volume":"46","author":"D Storch","year":"2005","journal-title":"J Nucl Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e0170435","DOI":"10.1371\/journal.pone.0170435","article-title":"Radioiodinated exendin-4 is superior to the radiometal-labelled glucagon-like peptide-1 receptor probes overcoming their high kidney uptake","volume":"12","author":"T L\u00e4ppchen","year":"2017","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1200\/JCO.2014.60.2532","article-title":"Carcinoid and neuroendocrine tumors: building on success","volume":"33","author":"PL Kunz","year":"2015","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"ref26","doi-asserted-by":"crossref","first-page":"54S","DOI":"10.2967\/jnumed.117.191015","article-title":"Somatostatin receptor 2-targeting compounds","volume":"58","author":"DA Smit Duijzentkunst","year":"2017","journal-title":"J Nucl Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1002\/ejic.200500579","article-title":"Kinetic inertness and electrochemical behavior of Copper (II) tetraazamacrocyclic complexes: possible implications for in vivo stability","author":"SL Woodlin","year":"2005","journal-title":"Eur J Inorg Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2967\/jnumed.114.138834","article-title":"Comparison of somatostatin receptor agonist and antagonist for peptide receptor radionuclide therapy: a pilot study","volume":"55","author":"D Wild","year":"2014","journal-title":"J Nucl Med"},{"key":"ref29","article-title":"Comparison of (68)Ga-OPS202 ((68)Ga-NODAGA-JR11) and (68)Ga-DOTATOC ((68)Ga-Edotreotide) PET\/CT in patients with gastroenteropancreatic neuroendocrine tumors: evaluation of sensitivity in a prospective phase II imaging study","author":"GP Nicolas","year":"2017","journal-title":"J Nucl Med"},{"key":"ref30","article-title":"Safety, biodistribution, and radiation dosimetry of (68)Ga-OPS202 ((68)Ga-NODAGA-JR11) in patients with gastroenteropancreatic neuroendocrine tumors: a prospective phase I imaging study","author":"GP Nicolas","year":"2017","journal-title":"J Nucl Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1039\/C3DT52647J","article-title":"PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate","volume":"43","author":"BM Paterson","year":"2014","journal-title":"Dalton Trans"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11307-013-0717-9","article-title":"Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin \u03b1v\u03b2 6","volume":"16","author":"LY Hu","year":"2014","journal-title":"Mol Imaging Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1039\/c3an00527e","article-title":"Fast and simultaneous analysis of biothiols by high performance liquid chromatography with fluorescence detection under hydrophilic interaction chromatography conditions","volume":"138","author":"M Isokawa","year":"2013","journal-title":"Analyst"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchromb.2015.11.038","article-title":"Determination and characterization of total thiols in mouse serum samples using hydrophilic interaction liquid chromatography with fluorescence detection and mass spectrometry","volume":"1019","author":"M Isakowa","year":"2016","journal-title":"J Chromatogr B"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0195802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T04:58:14Z","timestamp":1540357094000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0195802"}},"subtitle":[],"editor":[{"given":"Christoph E.","family":"Hagemeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,18]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0195802","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,18]]}}}